Navigating the New EU Medical Devices Regulation: Retrospective Post-Market Follow-Up of Hyaluronic Acid Injections for Knee Osteoarthritis

Overview

Journal Open Access Rheumatol

Publisher Dove Medical Press

Specialty Rheumatology

Date 2024 Mar 26

PMID 38529260

Authors

Alejandro Alcina Navarro

Sara Gomez Valero

Mercedes Gimeno Del Sol

Maria Pilar Coronel Granado

Affiliations

Soon will be listed here.

Abstract

Purpose: The entry into force of the new Medical Device Regulation (EU) 2017/745 highlights the need for post-market clinical follow-up to ensure the safety and efficacy throughout the life cycle of medical devices. This study evaluates the efficacy and safety of a single intra-articular hyaluronic acid injection in knee osteoarthritis in real-world conditions, over a six-month period, aligning with the summary of safety and clinical performance (SSCP) required by the new regulation.

Patients And Methods: Patients over 18 years of age with knee osteoarthritis, treated with a single injection of HA (Adant One, Meiji Pharma Spain, Spain) at a 3rd level hospital. Patients were treated and followed between January 1, 2020 and June 30, 2022. Demographic, clinical, and treatment-related data were collected, and efficacy regarding pain relief and/or function improvement was assessed using a Likert-type scale. Data were pseudo-anonymized and the comparison was performed using Fisher' or Mann Whitney' test. The study was approved by the Ethics Review Board of the Hospital Puerta de Hierro (Madrid, Spain).

Results: We followed 20 patients with knee osteoarthritis, with a mean age of 61 years, 80% women, and with a high burden of comorbidities (90%). A total of 60% of patients presented Kellgren-Lawrence grade III-IV. Four patients (20%) returned before 6 months due to lack of efficacy. Of the other patients, 65% showed a clinical response that lasted more than 12 months in 38.5% of cases. Time until medical appointment and taking concomitant medication for knee osteoarthritis were associated with better clinical response (p < 0.05).

Conclusion: The administration of a Adant One single intra-articular hyaluronic acid injection in knee osteoarthritis is effective, safe, and maintains the improvement over a six-month period. Our findings also emphasize the need of using standardized tools for accurate efficacy assessment and optimal patient care.

References

Sanchez Romero E, Fernandez-Carnero J, Calvo-Lobo C, Ochoa Saez V, Burgos Caballero V, Pecos-Martin D . Is a Combination of Exercise and Dry Needling Effective for Knee OA?. Pain Med. 2019; 21(2):349-363. DOI: 10.1093/pm/pnz036. View

Abramoff B, Caldera F . Osteoarthritis: Pathology, Diagnosis, and Treatment Options. Med Clin North Am. 2020; 104(2):293-311. DOI: 10.1016/j.mcna.2019.10.007. View

van Schoor N, Zambon S, Castell M, Cooper C, Denkinger M, Dennison E . Impact of clinical osteoarthritis of the hip, knee and hand on self-rated health in six European countries: the European Project on OSteoArthritis. Qual Life Res. 2015; 25(6):1423-32. PMC: 4870285. DOI: 10.1007/s11136-015-1171-8. View

Kellgren J, Lawrence J . Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957; 16(4):494-502. PMC: 1006995. DOI: 10.1136/ard.16.4.494. View

Yaftali N, Weber K . Corticosteroids and Hyaluronic Acid Injections. Clin Sports Med. 2018; 38(1):1-15. DOI: 10.1016/j.csm.2018.08.006. View

Costa F, Costa Marques M, Costa V, Santos G, Martins R, Santos M . Intra-Articular Hyaluronic Acid in Osteoarthritis and Tendinopathies: Molecular and Clinical Approaches. Biomedicines. 2023; 11(4). PMC: 10135595. DOI: 10.3390/biomedicines11041061. View

Yang G, Wang J, Liu Y, Lu H, He L, Ma C . Burden of Knee Osteoarthritis in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019. Arthritis Care Res (Hoboken). 2023; 75(12):2489-2500. DOI: 10.1002/acr.25158. View

Bruyere O, Honvo G, Veronese N, Arden N, Branco J, Curtis E . An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019; 49(3):337-350. DOI: 10.1016/j.semarthrit.2019.04.008. View

Altman R, Manjoo A, Fierlinger A, Niazi F, Nicholls M . The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015; 16:321. PMC: 4621876. DOI: 10.1186/s12891-015-0775-z. View

10.

Gavin C, Blanco F, Pablos J, Caracuel M, Rosas J, Gomez-Barrena E . One-Year, Efficacy and Safety Open Label Study, with a Single Injection of a New Hyaluronan for Knee OA: The SOYA Trial. J Pain Res. 2021; 14:2229-2237. PMC: 8312328. DOI: 10.2147/JPR.S321841. View

11.

Overton C, Nelson A, Neogi T . Osteoarthritis Treatment Guidelines from Six Professional Societies: Similarities and Differences. Rheum Dis Clin North Am. 2022; 48(3):637-657. PMC: 9377706. DOI: 10.1016/j.rdc.2022.03.009. View

12.

Phillips M, Bhandari M, Grant J, Bedi A, Trojian T, Johnson A . A Systematic Review of Current Clinical Practice Guidelines on Intra-articular Hyaluronic Acid, Corticosteroid, and Platelet-Rich Plasma Injection for Knee Osteoarthritis: An International Perspective. Orthop J Sports Med. 2021; 9(8):23259671211030272. PMC: 8414628. DOI: 10.1177/23259671211030272. View

13.

Bannuru R, Osani M, Vaysbrot E, Arden N, Bennell K, Bierma-Zeinstra S . OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019; 27(11):1578-1589. DOI: 10.1016/j.joca.2019.06.011. View

14.

Navarro-Sarabia F, Coronel P, Collantes E, Navarro F, de la Serna A, Naranjo A . A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011; 70(11):1957-62. PMC: 3184238. DOI: 10.1136/ard.2011.152017. View

15.

Deveza L, Melo L, Yamato T, Mills K, Ravi V, Hunter D . Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review. Osteoarthritis Cartilage. 2017; 25(12):1926-1941. DOI: 10.1016/j.joca.2017.08.009. View

16.

Hunter D, Bierma-Zeinstra S . Osteoarthritis. Lancet. 2019; 393(10182):1745-1759. DOI: 10.1016/S0140-6736(19)30417-9. View

17.

Maheu E, Rannou F, Reginster J . Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016; 45(4 Suppl):S28-33. DOI: 10.1016/j.semarthrit.2015.11.008. View

18.

Conrozier T, Diracoglu D, Monfort J, Chevalier X, Bard H, Baron D . EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis. Cartilage. 2022; 14(2):125-135. PMC: 10416196. DOI: 10.1177/19476035221138958. View

19.

Iuamoto L, Ito F, Tome T, Hsing W, Meyer A, Imamura M . Effects of neuroplasticity in people with knee osteoarthritis: A systematic review of the literature. Medicine (Baltimore). 2022; 101(3):e28616. PMC: 8772630. DOI: 10.1097/MD.0000000000028616. View

20.

Trojian T, Concoff A, Joy S, Hatzenbuehler J, Saulsberry W, Coleman C . AMSSM scientific statement concerning viscosupplementation injections for knee osteoarthritis: importance for individual patient outcomes. Br J Sports Med. 2016; 50(2):84-92. DOI: 10.1136/bjsports-2015-095683. View